» Authors » Sebastian Jander

Sebastian Jander

Explore the profile of Sebastian Jander including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 77
Citations 1980
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Weiss D, Rubbert C, Kaschner M, Greiner G, Kairies-Schwarz N, Vomhof M, et al.
BMC Emerg Med . 2024 Nov; 24(1):224. PMID: 39604854
Background: The reduction of processing times in the treatment of acute ischemic stroke is of outstanding importance. Our objective is to analyze the acute stroke care chain from onset to...
2.
Wiendl H, Abicht A, Chan A, Marina A, Hagenacker T, Hekmat K, et al.
Ther Adv Neurol Disord . 2023 Dec; 16:17562864231213240. PMID: 38152089
Myasthenia gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS), and congenital myasthenic syndromes (CMS) represent an etiologically heterogeneous group of (very) rare chronic diseases. MG and LEMS have an autoimmune-mediated etiology, while...
3.
Weiss D, Rubbert C, Kaschner M, Jander S, Gliem M, Lee J, et al.
Neurol Res . 2022 Dec; 45(5):449-455. PMID: 36480518
Purpose: Two strategies of initial patient care exist in endovascular thrombectomy (ET) depending on the site of initial admission: the mothership (MS) and drip-and-ship (DnS) principles. This study compares both...
4.
Weiss D, Rubbert C, Ivan V, Lee J, Gliem M, Jander S, et al.
Neuroradiol J . 2022 Jan; 35(5):600-606. PMID: 35083935
Purpose: Endovascular treatment (ET) in occlusions of the M1- and proximal M2-segment of the middle cerebral artery (MCA) is an established procedure. In contrast, ET in distal M2-occlusions has not...
5.
Vornholz L, Nienhaus F, Gliem M, Alter C, Henning C, Lang A, et al.
Front Physiol . 2022 Jan; 12:782760. PMID: 34992548
Patients with acute ischemic stroke (AIS) present an increased incidence of systemic inflammatory response syndrome and release of Troponin T coinciding with cardiac dysfunction. The nature of the cardiocirculatory alterations...
6.
Pavic G, Petzsch P, Jansen R, Raba K, Rychlik N, Simiantonakis I, et al.
Glia . 2021 Aug; 69(11):2739-2751. PMID: 34390590
Inflammation after injury of the central nervous system (CNS) is increasingly viewed as a therapeutic target. However, comparative studies in different CNS compartments are sparse. To date only few studies...
7.
Jansen R, Lee J, Turowski B, Kaschner M, Caspers J, Bernhard M, et al.
Neurol Res Pract . 2021 Apr; 3(1):21. PMID: 33789760
Background: COVID-19 pandemic caused a decline in stroke care in several countries. The objective was to describe lockdown stroke care in a tertiary stroke center in Düsseldorf, Germany near Heinsberg,...
8.
Schroeter M, Berger B, Blaes F, Hagenacker T, Jander S, Kaiser J, et al.
J Cent Nerv Syst Dis . 2021 Feb; 13:1179573521989151. PMID: 33597816
Background And Purpose: In 2017, eculizumab has been approved for treatment-refractory generalised myasthenia gravis (TRgMG). The German Myasthenia Foundation has published a consensus statement on the use of eculizumab, with...
9.
Lee J, Jansen A, Samadzadeh S, Kahlen U, Moll M, Ringelstein M, et al.
Ann Clin Transl Neurol . 2020 Dec; 8(1):15-28. PMID: 33259153
Objective: The objective of the study was the analysis of adherence and self-perceived treatment response to long-term botulinum neurotoxin type A (BoNT-A) treatment in different neurological indications. Methods: In this...
10.
Lee J, Gemerzki L, Weise M, Boerker L, Graf J, Jansen L, et al.
BMC Neurol . 2020 Sep; 20(1):333. PMID: 32883246
Background: It is unknown whether microangiopathic ischemic strokes outside the visual pathway go along with subclinical changes of the retinal structure or the visual system. The objectives of this prospective...